The agmdhope’s Podcast

Gastroparesis and Functional Dyspepsia - Are They the Same or Different? - April 2021

AGMD is proud to present our Conversations with Dr. Kenneth Koch series.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be highlighting Gastroparesis and Functional Dyspepsia - Are They the Same or Different?
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 
This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |. For more information, visit our website at www.agmdhope.org

Gastroparesis Awareness Month Special - Ask Dr. Koch - August 2021

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we have a conversation with Dr. Koch focusing on various topics related to gastroparesis.
 
August is Gastroparesis Awareness Month. We will be presenting a special program entitled, "Ask Dr. Koch."
 
During the program, Dr. Koch will respond to questions submitted by our audience participants.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

AGMD Conversations with Dr. Kenneth Koch - The Autonomic Nervous System, POTS, and Gastroparesis - June 2021

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be highlighting the autonomic nervous system, POTS, and gastroparesis.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 

Conversations with Dr. Kenneth Koch: Gastroparesis and Functional Dyspepsia - Are They The Same or Different - April 2021

AGMD is proud to present our Conversations with Dr. Kenneth Koch series.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be highlighting Gastroparesis and Functional Dyspepsia - Are They the Same or Different?
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

Gastroparesis and Pain - November 2020

AGMD is proud to present a new series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be highlighting gastroparesis and pain.
 
There will be ample time for audience questions towards the end of the interview.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

An Interview Part II Featuring Dr. Kenneth Koch Focusing On Gastroparesis - September 2020

AGMD is privileged to present a second Interview with Kenneth Koch, MD
During this part II interview, Dr. Koch will be talking about gastroparesis.
Towards the end of the program, there will be ample time for questions from the audience participants.
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

Vagus Nerve, Fundoplication, & Post Surgical Gastroparesis - February 2021

AGMD is proud to present a new series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be discussing the vagus nerve, fundoplication and post surgical gastroparesis.
 
There will be ample time for audience questions towards the end of the interview.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

An Interview Featuring Dr. Kenneth Koch Focusing On Gastroparesis - August 2020

AGMD is privileged to present an Interview with Kenneth Koch, MD
During the interview, Dr. Koch will be talking about gastroparesis.
Towards the end of the program, there will be ample time for questions from the audience participants.
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.